The largest database of trusted experimental protocols

40 protocols using alexa 488

1

Evaluating Anticancer Drug Effects on Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Optical microscope (Japan OLYMPUS IX71), 36.5°C CO2 incubator (US THERMO FISHER), Shenfu injection (Yaan Sanjiu Pharmaceutical Co., Ltd., batch number 17110205003), paclitaxel injection (Haikou Pharmaceutical Co., Ltd., batch number 12180708), CCK- 8 (Japan DOJINDO), JC-1 probe (US THERMO FISHER), β-tubulin III, Alexa 488, DEME medium, DEME/F12 medium, PBS, collagenase type I, trypsin I, and Alexa 488 were purchased from Sigma.
+ Open protocol
+ Expand
2

ROS Accumulation and HR Response in Wheat Leaves

Check if the same lab product or an alternative is used in the 5 most similar protocols
BSMV: TaHPPD and control leave samples of 48 and 120 hpi were observed for ROS accumulation by DAB staining and HR response areas by autofluorescence of necrotic cells under an Olympus BX-51 fluorescence microscope (Olympus Corp., Tokyo, Japan). For the DAB staining experiment, the infected wheat leaves were submerged in the 1 mg/mL DAB solution for 8 h under bright light. After immersed in the buffer the leaves were cut up, and decolored with the decolorizing solution (absolute ethyl alcohol: acetic acid, 1:1 v/v).
As previously described method (Wang et al. 2017 (link)), wheat germ agglutinin (WGA) coupled with Alexa 488 (Sigma-Aldrich, Shanghai, China) fluorescein was used to stain the infection structure of Pst in TaHPPD-silencing plant and control. For each treatment, at least 30 infection sites were examined in 5–10 randomly selected leaf segments. Substomatal vesicles were regarded as successful penetration at infection sites. Using the SPSS program (SPSS, Inc. Chicago, United States), standard deviations were calculated and the Tukey's test was executed for statistical analysis.
+ Open protocol
+ Expand
3

Purification and Labeling of Recombinant Hsp70

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human Hsp70 was purified from E. coli (strain BL21 DE3), transformed with a pMS-Hsp70 plasmid, as previously described20 (link). The Hsp70 solution was further detoxified by incubation with Detoxi-Gel Endotoxin Remover Resin (Thermo Scientific, USA) and sterilized by filtration through a 0.22 µm filter (Millipore, USA). According to the E-Toxate assay (Sigma-Aldrich, USA), the level of lipopolysaccharide in the final Hsp70 preparation was lower than 0.25 U/mL. For flow cytometry and confocal experiments, Hsp70 was labeled with Alexa-555 or Alexa-488 or with NHS–biotin (Sigma, USA), according to manufacturer’s instructions. To remove unbound dye (or non-reacted biotin) after labeling the protein was subjected to the dialysis: twice at room temperature for 1 h, and then at 4 °C overnight, stirring.
+ Open protocol
+ Expand
4

ICAM-1 Expression Assay for Anti-Inflammatory Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
ICAM-1 expression assay was performed as described previously [19] (link). Shortly, HUVECs (2×104/ml), grown in either transparent 96-well plates and adhered for 6 h, were incubated for 1h with 25 µg/ml compound AA, BB, C, D or crude extract and stimulated with the pro-inflammatory cytokine TNF-alpha (20 ng/ml) for further 18 h. Subsequently, the level of ICAM-1 expression can be quantified by means of cell-based ELISA. Upon washing with PBS and fixing the cells for 2 min with methanol (−20°C), wells were subsequently blocked from unspecific binding with PBS+5% BSA. Subsequently, ICAM-1 expression was assessed using a monoclonal anti-human ICAM-1 (CD 54) (Clone 8.4A6) purified mouse Immunoglobulin (1 µg/ml, Sigma, Austria) or an isotype-matched control IgG (1 µg/ml, Sigma, Austria) as the primary antibody and a goat anti-mouse polyclonal antibody labelled with Alexa-488 (1 µg/ml, Sigma, Austria) as a secondary antibody. After washing, the fluorescence was then detected in the multiplate Reader (EX/EM 485/535). The % of ICAM-1 upregulation was then calculated as follows: % of basal ICAM-1  =  (Test Signal –Control antibody signal)/(Basal signal – control antibody signal) x 100%.
+ Open protocol
+ Expand
5

Retinal Explant Visualization in PTEN Mutant Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
PTENf/f mice at P21 were injected with AAV2-Cre first and 24h later with AAV2-PLAP as a control or other AAV2 vectors. 2 weeks after, retinas were dissected out in Hibernate-A (Brain Bits). Retinal explants were then plated onto Poly-L-Lysin and Laminin (Sigma) coated glass bottom dishes (MatTek) in Neurobasal-A (Life Technology) supplemented with B-27, L-Glutamine (Life Technology) and Penicillin/Streptomycin. After 2 weeks, explants were fixed in PFA 4%/Sucrose 1.5% in PBS and labeled with primary antibodies, anti-Tuj1 (1/400), anti-DCLK2 (1/200-AbCAM) and secondary antibodies, Alexa-488, Alexa-674, and Phalloidin-TRITC (1/800-Sigma).
+ Open protocol
+ Expand
6

Fluorescent Labeling of Proteins and Nanobodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conjugation of protein or nanobody was performed with an eightfold (laminin; Roche, 11243217001) or fourfold (R2-myc-his; a gift from S. Oliveira) molar excess of NHS ester (ATTO 425, ATTO 647N; ATTO-TEC, Alexa 488, Alexa 594; Sigma-Aldrich) in a minimal volume (<50 µl) of Milli-Q water (MQ). Protein/nanobody and NHS ester were mixed by vortexing and incubated overnight at 4 °C before storing 10-µg aliquots at −20 °C. Fibrinogen pre-conjugated with Alexa Fluor 647 (Invitrogen, F35200) was reconstituted in 0.1 M sodium bicarbonate buffer, pH 8.3, and aliquots were stored at −20 °C.
+ Open protocol
+ Expand
7

Muscle Fiber Characterization via Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transverse serial sections of FDP muscle (10 μm thick) were obtained using a cryostat maintained at − 25 °C (HM-560, Microm H, Thermo Scientific, Waltham, Massassuchets, USA). Sections were stored at − 20 °C until histochemical staining. Before labeling, the sections were dried and fixed for 10 min in acetone. The sections were then washed in PBS, blocked and permeabilized with PBS 0.1% Triton X-100 and 20% horse serum.
For cross-sectional area (CSA) determination, the sections were incubated for 1 h with a rabbit anti-laminin antibody (1/400) (Sigma Aldrich, Saint-Louis, Missouri, USA), washed and then incubated with a secondary antibody conjugated to ALEXA 488 (goat anti-rabbit, Sigma, 1:800).
For muscle fiber typing determination, the sections were incubated with anti-MHC primary antibodies (anti-slow (I) MyHC, BA-D5, Developmental Studies Hybridoma Bank, 1:10 and anti-fast (II) MyHC, M4276, Sigma-Aldrich, 1:200) for 1 h at 37 °C, followed by washes in PBS and incubation with the secondary antibodies (1/800) (ALEXA 488; ALEXA 568, A11031, Invitrogen, Carlsbad, California, USA,) for 1 h.
The sections were scanned using a Nanozoomer (Hamamatsu), and CSA and fiber typing and were determined using ImageJ® software (version 1.46r).
+ Open protocol
+ Expand
8

Immunofluorescence Labeling of Brain Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Free-floating sections were washed in TBS, blocked with 5% bovine serum albumin (BSA; New England BioLabs, Ipswich, MA, USA) containing 0.1% Triton X-100 for 1 h at room temperature to reduce non-specific staining and incubated in primary antibody solution containing 2% BSA, 0.25% Triton X-100, 0.1% NaN3 in 0.1 M TBS for 48 h at room temperature. The following primary antibodies were used: anti-βIV-spectrin (rabbit, 1:500; selfmade, see Schlüter et al., 2017 (link)), anti-synaptopodin (rabbit, polyclonal, 1:1,000; Synaptic Systems, Göttingen, Germany) and anti-GFP488 (mouse, 1:500, fluorescence-labeled Alexa 488; Sigma-Aldrich). For immunofluorescence detection, sections were incubated with secondary fluorescence-labeled antibodies (1:1,000; Alexa 488, 568, 633; Vector Labs., Burlingame, CA, USA) for 24 h at room temperature.
+ Open protocol
+ Expand
9

Fluorescent Nanoparticle Synthesis and Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
NPs were prepared using the flash nanoprecipitation (FNP) method as detailed in Electronic Supplementary Material (ESM) (Fig. 1a) [23 (link)]. Some NPs were tagged with a fluorophore, and, in particular, NPs of three different diameters were labeled with three different fluorophores (Alexa-488, Alexa-405, and Alexa-647, Sigma, USA) using FNP allowing for in vivo PAI and ex vivo fluorescent imaging (FI) investigations in the same animal as described in “PAI” and “FI”. The NP optical properties used in this study are reported in Table 1.
+ Open protocol
+ Expand
10

Quantifying TGFB Signaling in Mammary Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages positive for phosphorylated SMAD2, indicative of TGFB signalling [31 (link)], were detected by immunofluorescent staining of the formalin-fixed paraffin-embedded mammary glands. Following antigen retrieval, F4/80 antibody conjugated to Alexa-750 (Caltag Laboratories, Burlingame, CA, USA) and rabbit anti-pSMAD2 monoclonal antibody (Invitrogen) both at a 1:100 dilution were incubated with the slides overnight at 4 °C. Goat anti-rabbit antibody conjugated to Alexa-488 was used to detect pSMAD2 (1:500 dilution; 1 h at 4 °C) followed by 4′, 6-diamidino-2-phenylindol (DAPI) (Sigma, St Louis, USA) staining for 10 min at 1:1000 dilution. Images were captured and collected using an Olympus FV3000 Confocal Microscope at × 40 magnification. Macrophages were selected randomly for imaging, and the number of macrophages positive for pSMAD2 quantified and expressed as percent positive per mammary gland.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!